Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2021 | 1 |
2022 | 3 |
2023 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data.
Cell Rep Methods. 2023 Mar 6;3(3):100417. doi: 10.1016/j.crmeth.2023.100417. eCollection 2023 Mar 27.
Cell Rep Methods. 2023.
PMID: 37056380
Free PMC article.
Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies.
Melvold K, Giliberto M, Karlsen L, Ayuda-Durán P, Hanes R, Holien T, Enserink J, Brown JR, Tjønnfjord GE, Taskén K, Skånland SS.
Melvold K, et al. Among authors: giliberto m.
Mol Oncol. 2022 Mar;16(5):1153-1170. doi: 10.1002/1878-0261.13153. Epub 2021 Dec 18.
Mol Oncol. 2022.
PMID: 34861096
Free PMC article.
Item in Clipboard
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines.
Giliberto M, Santana LM, Holien T, Misund K, Nakken S, Vodak D, Hovig E, Meza-Zepeda LA, Coward E, Waage A, Taskén K, Skånland SS.
Giliberto M, et al.
Front Oncol. 2022 Nov 29;12:1040730. doi: 10.3389/fonc.2022.1040730. eCollection 2022.
Front Oncol. 2022.
PMID: 36523963
Free PMC article.
Item in Clipboard
Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically.
Giliberto M, Thimiri Govinda Raj DB, Cremaschi A, Skånland SS, Gade A, Tjønnfjord GE, Schjesvold F, Munthe LA, Taskén K.
Giliberto M, et al.
Mol Oncol. 2022 Mar;16(6):1241-1258. doi: 10.1002/1878-0261.13191. Epub 2022 Mar 12.
Mol Oncol. 2022.
PMID: 35148457
Free PMC article.
Item in Clipboard
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss.
Zahoor M, Westhrin M, Aass KR, Moen SH, Misund K, Psonka-Antonczyk KM, Giliberto M, Buene G, Sundan A, Waage A, Sponaas AM, Standal T.
Zahoor M, et al. Among authors: giliberto m.
Blood Adv. 2017 Dec 13;1(27):2656-2666. doi: 10.1182/bloodadvances.2017010801. eCollection 2017 Dec 26.
Blood Adv. 2017.
PMID: 29296919
Free PMC article.
Item in Clipboard
Cite
Cite